CautionRoaccutane
Isotretinoin
Oral retinoid
Extreme teratogen — Pregnancy Prevention Programme mandatory.
Oral
First-line for
- Severe recalcitrant nodulocystic acne (specialist)
Mechanism
Vitamin A analogue → ↓ sebaceous gland activity, keratinisation modulation, anti-inflammatory.
"Roaccutane = 1 pregnancy = catastrophic"
- MHRA PPP: two contraceptives + monthly PPT
- Do NOT donate blood during or 1 month after
- MHRA 2023: mental health and sexual dysfunction warnings
Dosing
- Adult
- 0.5–1 mg/kg/day divided; cumulative dose 120–150 mg/kg per course
Contraindications
- AbsolutePregnancy — retinoid embryopathy
- AbsoluteBreastfeeding
- AbsoluteConcurrent tetracyclines (raised ICP)
- AbsoluteHepatic impairment, hypervitaminosis A
Side effects
- Cheilitis, dry skin/eyes
- Photosensitivity
- ↑ LFTs, ↑ triglycerides
- Depression, suicidal ideation (rare, monitor)
- Sexual dysfunction (MHRA 2023)
Fetal & maternal notes
- • Retinoid embryopathy: craniofacial, cardiac (conotruncal), thymic, CNS (hydrocephalus)
- • Effective contraception 1 month before, during, and 1 month after
Key interactions
Tetracyclines
AvoidIdiopathic intracranial hypertension
Vitamin A supplements
AvoidAdditive toxicity
Micro-progestogen contraception (POP)
CautionConsidered insufficient alone
Clinical pearls
- 💡 Always double-contraception advice + monthly PPT before dispensing
- 💡 Baseline + monthly lipids and LFTs
Content last reviewed: REPLACE_ME (e.g. 2026-07)
Spotted something out of date? See our disclaimer or use Report an Error above.